• Return to Headlines

Shares of Celgene Corp Rise to a New 52-Week High

By Amy Schwartz

Celgene Corp (NASDAQ:CELG) traded today at a new 52-week high of $109.07. So far today approximately 334,000 shares have been exchanged, as compared to an average 30-day volume of 3 million shares.

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide.

Celgene Corp (NASDAQ:CELG) has potential upside of 3.9% based on a current price of $108.85 and analysts' consensus price target of $113.09. The stock should discover initial support at its 50-day moving average (MA) of $99.84 and subsequent support at its 200-day MA of $94.09.

Celgene Corp share prices have moved between a 52-week high of $109.07 and a 52-week low of $58.59 and are now trading 86% above that low price at $108.85 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.9%.

SmarTrend is tracking the current trend status for Celgene Corp and will alert subscribers who have CELG in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows celgene corp

Ticker(s): CELG